Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/ MS/MS) of urine drug testing

Pain Physician

Volumn 14, Issue 3, 2011, Pages 259-270

  Manchikanti, Laxmaiah ^a   Malla, Yogesh ^a   Wargo, Bradley W ^a   Fellows, Bert ^a  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

Author keywords

Abuse; Benzodiazepines; Controlled substances; Illicit drugs; Immunoassay; Liquid chromatography tandem mass spectrometry; Opioids; Urine drug testing

Indexed keywords

BENZODIAZEPINE;

ADULT; ARTICLE; CHRONIC PAIN; CHRONIC PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG SCREENING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PREDICTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDITY;

ADULT; BENZODIAZEPINES; CHROMATOGRAPHY, LIQUID; CHRONIC PAIN; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PAIN, INTRACTABLE; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 79957874735     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective. Pain Physician 2010; 13:401-435.
2. Manchikanti L, Damron KS, McManus CD, Barnhill RC. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician 2004; 7:431-437.
3. Trescot AM, Helm S, Hansen H, Be-nyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) guidelines. Pain Physician 2008; 11:S5-S62.
4. Most Commonly Prescribed Drugs. Blue Cross Blue Shield of Texas 2009. www.bcbstx.com/pdf/druglist.pdf
5. Manchikanti L, Manchikanti KN, Pam-pati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzo-diazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009; 12:259-267.
6. West R, Pesce A, West C, Crews B, Mikel C, Almazan P, Rosenthal M, Latyshev S. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population. Pain Physician 2010; 13:71-78.
7. Substance Abuse and Mental Health Services Administration (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NS-DUH Series H-38A, HHS Publication No. SMA 10-4586Findings). Rockville, MD. www.oas.samhsa.gov/NSDUH/2k9NSDUH/2k9ResultsP.pdf
8. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2007: National Estimates of Drug-Related Emergency Department Visits. Rock-ville, MD, 2010. dawninfo.samhsa.gov/files/ED2007/DAWN2k7ED.pdf
9. Manchikanti L, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: An evaluation of patterns and trends. J Ky Med Assoc 2005; 103:55-62.
10. Manchikanti L, Manchukonda R, Dam-ron KS, Brandon D, McManus CD, Cash KA. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006; 9:57-60.
11. Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC, Fellows B. Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J Ky Med As-soc 2003; 101:511-517.
12. Fisher J, Sanval C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programmes: A review of the literature. J Clin Pharm Ther 2011; 17:1365-2710.
13. Blencowe T, Raaska K, Lillsunde P. Ben-zodiazepines and sedative-hypnotics in blood of drivers under the influence and their association with other common illegal drug use and national sales figures. Ther Drug Monit 2011; 33:64-71.
14. McGerald G, Dvorkin R, Levy D, Lovell-Rose S, Sharma A. Prescriptions for schedule II opioids and benzodiaze-pines increase after the introduction of computer-generated prescriptions. Acad Emerg Med 2009; 16:508-512.
15. Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C. Are we going to increase the use of antidepres-sants up to that of benzodiazepines? Eur J Clin Pharmacol 2004; 60:629-634.
16. Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith HS. Opioids in chronic non-cancer pain. Expert Rev Neurother 2010; 10:775-789.
17. Mularski RA, White-Chu F, Overbay D, Miller L, Asch SM, Ganzini L. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med 2006; 21:607-612.
18. Califano JA. High Society: How Substance Abuse Ravages America and What to Do About It. Perseus Publishing, New York, 2007.
19. Roškar R, Sollner Dolenc M. Determination of benzodiazepines in urine via benzophenone derivatives using liquid chromatography-tandem mass spec-trometry. Arh Hig Rada Toksikol 2010; 61:381-388.
20. Lader M. Anxiolytic drugs: Dependence, addiction and abuse; Eur Neuropsycho-pharmacol 1994; 4:85-91.
21. Lavie E, Fatseas M, Denis C, Auria-combe M. Benzodiazepine use among opiate-dependent subjects in buprenor-phine maintenance treatment: Correlates of use, abuse, and dependence. Drug Alcohol Depend 2009; 99:338-344.
22. Barnas C, Rossmann M, Roessler H, Re-imer Y, Fleischhacker WW. Benzodiaz-epines and other psychotropic-drugs abused by patients in a methadone-maintenance program: Familiarity and preference. J Clin Psychopharmacol 1992; 12:397-402.
23. Bramness JG, Kornor H. Benzodiaze-pine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend 2007; 90:203-209.
24. Manchikanti L, Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12:E35-E70.
25. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, Castel LD, Kalsbeek WD, Carey TS. The rising prevalence of chronic low back pain. Arch Intern Med 2009; 169:251-258.
26. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for in-terventional techniques in the manage-ment of chronic spinal pain. Pain Physician 2009; 12:699-802.
27. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: Time to back off? J Am Board Fam Med 2009; 22:62-68.
28. Manchikanti L, Singh V, Pampati V, Smith HS, Hirsch JA. Analysis of growth of interventional techniques in managing chronic pain in Medicare population: A 10-year evaluation from 1997 to 2006. Pain Physician 2009; 12:9-34.
29. Manchikanti L, Pampati V, Singh V, Bo-swell MV, Smith HS, Hirsch JA. Explosive growth of facet joint interventions in the Medicare population in the United States: A comparative evaluation of 1997, 2002, and 2006 data. BMC Health Serv Res 2010; 10:84.
30. Manchikanti L, Pampati V, Boswell MV, Smith HS, Hirsch JA. Analysis of the growth of epidural injections and costs in the Medicare population: A comparative evaluation of 1997, 2002, and 2006 data. Pain Physician 2010; 13:199-212.
31. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampa-ti V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manage 2007; 3:89-100.
32. Dersh J, Mayer T, Theodore BR, Pola-tin P, Gatchel RJ. Do psychiatric disorders first appear preinjury or postinju-ry in chronic disabling occupational spinal disorders? Spine (Phila Pa 1976) 2007; 32:1045-1051.
33. Rivera JJ, Singh V, Fellows B, Pampati V, Damron KS, McManus CD. Reliability of psychological evaluation in chronic pain in an interventional pain management setting. Pain Physician 2005; 8:375-383.
34. Manchikanti L, Cash KA, Pampati V, Fellows B. Influence of psychological variables on the diagnosis of facet joint involvement in chronic spinal pain. Pain Physician 2008; 11:145-160.
35. Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Evaluation of psychological status in chronic low back pain: Comparison with general population. Pain Physician 2002; 5:149-155.
36. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: A prospective analysis of immunoassay and liquid chromatogra-phy tandem mass spectometry (LC/MS/MS). Pain Physician 2010; 13:E1-E22.
37. Christo PJ, Manchikanti L, Ruan X, Bot-tros M, Hansen H, Solanki D, Jordan AE, Colson J. Urine drug testing in chronic pain. Pain Physician 2011; 14:123-143.
38. Manchikanti L, Malla Y, Wargo BW, Fellows B. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spec-trometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Pain Physician 2011; 14:175-187.
39. Stout PR, Bynum ND, Mitchell JM, Baylor MR, Ropero-Miller JD. A comparison of the validity of gas chromatography-mass spectrometry and liquid chroma-tography-tandem mass spectrometry analysis of urine samples for morphine, codeine, 6-acetylmorphine, and benzo-ylecgonine. J Anal Toxicol 2009; 33:398-408.
40. Glover SJ, Allen KR. Measurement of benzodiazepines in urine by liquid chro-matography-tandem mass spectrome-try: Confirmation of samples screened by immunoassay. Ann Clin Biochem 2010; 47:111-117.
41. Lynch KL, Breaud AR, Vandenberghe H, Wu AH, Clarke W. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta 2010; 411:1474-1481.
42. Mikel C, Almazan P, West R, Crews B, Latyshev S, Pesce A, West C. LC-MS/ MS extends the range of drug analysis in pain patients. Ther Drug Monit 2009; 31:746-748.
43. Alfazema LN, Richards DS, Gélébart S, Mitchell JC, Snowden MJ. Rapid, accurate and precise quantitative drug analysis: Comparing liquid chromatogra-phy tandem mass spectrometry and chip-based nanoelectrospray ionisation mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) 2005; 11:393-402.
44. Duxbury K, Romagnoli C, Anderson M, Watts R, Waite G. Development of a clinically relevant liquid chromatogra-phy tandem mass spectrometry assay for 13 drugs of abuse in urine, designed to meet the needs of the service users. Ann Clin Biochem 2010; 47:415-422.
45. Tai SS, Prendergast JL, Sniegoski LT, Welch MJ, Phinney KW, Zhang NF. Certification of drugs of abuse in a human serum standard reference material: SRM 1959. Anal Bioanal Chem 2010; 397:501-509.
46. Bjørk MK, Nielsen MK, Markussen LØ, Klinke HB, Linnet K. Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2010; 396:2393-2401.
47. Pesce A, Rosenthal M, West R, West C, Mikel C, Almazan P, Latyshev S. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients. Pain Physician 2010; 13:273-281.
48. West R, Pesce A, West C, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S. Observations of medication compliance by measurement of urinary drug concentrations in a pain management population. J Opioid Manage 2010; 6:253-257.
49. Pesce A, West C, Rosenthal M, West R, Crews B, Mikel C, Almazan P, Latyshev S, Horn PS. Marijuana correlates with use of other illicit drugs in a pain patient population. Pain Physician 2010; 13:283-287.
50. Couto JE, Romney MC, Leider HL, Shar-ma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul Health Manage 2009; 12:185-190.
51. Manchikanti L, Singh V, Boswell MV. In-terventional pain management at crossroads: The perfect storm brewing for a new decade of challenges. Pain Physician 2010; 13:E111-E140.
52. Benyamin RM, Datta S, Falco FJE. A perfect storm in interventional pain management: Regulated, but unbalanced. Pain Physician 2010; 13:109-116.
53. Gilbert JW, Wheeler GR, Mick GE, Storey BB, Herder SL, Richardson GB, Watts E, Gyarteng-Dakwa K, Marino BS, Kenney CM, Siddiqi M, Broughton PG. Importance of urine drug testing in the treatment of chronic non-cancer pain: Implications of recent medicare policy changes in Kentucky. Pain Physician 2010; 13:167-186.
54. Gilbert JW, Wheeler GR, Mick GE, Storey BB, Herder SL, Richardson GB, Watts E, Gyarteng-Dakwa K, Marino BS, Kenney CM, Siddiqi M, Broughton PG. Urine drug testing in the treatment of chronic noncancer pain in a Kentucky private neuroscience practice: The potential effect of Medicare benefit changes in Kentucky. Pain Physician 2010; 13:187-194.
55. Dobson A, Heath S, El-Gamil A, DaVan-zo JE. Assessing potential Medicare savings from implementing a change in payment for selected clinical laboratory services. July 10, 2009. www.dobsondavanzo.com/clientup-loads/publications/Dominion_Diagnos-tics-Final_Draft7.10.09_v3.pdf
56. Ameritox Ltd., agrees to pay $16.3 mil lion to resolve kickback claims associat ed with laboratory testing services [press release]. United States Attorney's Office, Middle District of Florida; November 16, 2010. www.justice.gov/usao/flm/pr/2010/nov/20101116_%20Civil%20Ameritox.pdf
57. CMS Manual System. Pub 100-04 Medicare claims processing, Transmit-tal 1884, Change Request 6657. Calendar Year (CY) 2010 Annual Update for Clinical Laboratory Fee Schedule and Laboratory Services Subject to Reasonable Charge Payment. December 23, 2009. www.cms.gov/transmittals/downloads/R1884CP.pdf
58. Gambart D, Cardenas S, Gallego M, Val-carcel M. An automated screening system for benzodiazepines in human urine. Anal Chim Acta 1998; 366:93-102.
59. Cardenas S, Gallego M, Valcarcel M. Gas chromatographic-mass spectro-metric confirmation of selected benzo-phenones from benzodiazepines in human urine following automatic screening. J Chromatogr A 1998; 823:389-399.
60. Drummer OH. Methods for the measurement of benzodiazepines in biological samples. J Chromatogr B Biomed Sci Appl 1998; 713:201-225.
61. Beck O, Lafolie P, Hjemdahl P, Borg S, Odelius G, Wirbing P. Detection of ben-zodiazepine intake in therapeutic doses by immunoanalysis of urine: Two techniques evaluated and modified for improved performance. Clin Chem 1992; 38:271-275.
62. Meatherall R. Optimal enzymatic hydrolysis of urinary benzodiazepine conjugates. J Anal Toxicol 1994; 18:382-384.
63. Fraser AD, Meatherall R. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazol-am metabolites in urine: Effect of lowering the screening and GC-MS cut-off values. J Anal Toxicol 1996; 20:217-223.
64. Meatherall R, Fraser AD. Comparison of four immunoassays for the detection of lorazepam in urine. Ther Drug Monit 1998; 20:673-675.
65. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Li-jmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Clin Chem 2003; 49:1-6.
66. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 5. Diagnostic accuracy studies. Pain Physician 2009; 12:517-540.
67. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 7: Systematic reviews and meta-analyses of diagnostic accuracy studies. Pain Physician 2009; 12:929-963.
68. Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J 2003; 20:453-458.
69. Pergolizzi J, Pappagallo M, Stauffer J, Gharibo C, Fortner N, De Jesus MN, Brennan MJ, Richmond C, Hussey D; Integrated Drug Compliance Study Group (IDCSG). The role of urine drug testing for patients on opioid therapy. Pain Pract 2010; 10:497-507.
70. Nafziger AN, Bertino JS Jr. Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain 2009; 25:73-79.
71. Chou R, Huffman L. Guideline for the Evaluation and Management of Low Back Pain: Evidence Review. American Pain Society, Glenview, IL, 2009. www.ampainsoc.org/pub/pdf/LBPEvi-dRev.pdf
72. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
73. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-E79.
74. Manchikanti L, Datta S, Derby R, Wolfer LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for intervention-al techniques: Part 1. Diagnostic interventions. Pain Physician 2010; 13:E141-E174.
75. Manchikanti L, Datta S, Gupta S, Mung-lani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm II S, Fellows B, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2. Therapeutic interventions. Pain Physician 2010; 13:E215-E264.
76. Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 2010; 303:1259-1265.
77. Manchikanti L, Boswell MV, Singh V, Derby R, Fellows B, Falco FJE, Datta S, Smith HS, Hirsch JA. Comprehensive review of neurophysiologic basis and diagnostic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E71-E120.
78. Manchikanti L, Boswell MV, Datta S, Fellows B, Abdi S, Singh V, Benyamin RM, Falco FJE, Helm S, Hayek S, Smith HS. Comprehensive review of therapeutic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E123-E198.
79. Falco FJE, Erhart S, Wargo BW, Bryce DA, Atluri S, Datta S, Hayek SM. Systematic review of diagnostic utility and therapeutic effectiveness of cervical facet joint interventions. Pain Physician 2009; 12:323-344.
80. Datta S, Lee M, Falco FJE, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009; 12:437-460.
81. Conn A, Buenaventura R, Datta S, Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
82. Parr AT, Diwan S, Abdi S. Lumbar inter-laminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
83. Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
84. Buenaventura RM, Datta S, Abdi S, Smith HS. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 2009; 12:233-251.
85. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: A systematic review. Pain Physician 2009; 12:379-397.
86. Epter RS, Helm S, Hayek SM, Benya-min RM, Smith HS, Abdi S. Systematic review of percutaneous adhesiolysis and management of chronic low back pain in post lumbar surgery syndrome. Pain Physician 2009; 12:361-378.
87. Patel VB, Manchikanti L, Singh V, Schul-tz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
88. Rupert MP, Lee M, Manchikanti L, Dat-ta S, Cohen SP. Evaluation of sacroili-ac joint interventions: A systematic appraisal of the literature. Pain Physician 2009; 12:399-418.
89. Hirsch JA, Singh V, Falco FJE, Benyamin RM, Manchikanti L. Automated percutaneous lumbar discectomy for the contained herniated lumbar disc: A systematic assessment of evidence. Pain Physician 2009; 12:601-620.
90. Singh V, Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Percutaneous lumbar laser disc decompression: A systematic review of current evidence. Pain Physician 2009; 12:573-588.
91. Manchikanti L, Cash KA, McManus CD, Pampati V, Singh V, Benyamin RM. The preliminary results of a comparative effectiveness evaluation of adhesiolysis and caudal epidural injections in managing chronic low back pain secondary to spinal stenosis: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E341-E354.
92. Manchikanti L, Singh V, Cash KA, Pam-pati V, Datta S. A comparative effectiveness evaluation of percutaneous adhe-siolysis and epidural steroid injections in managing lumbar post surgery syndrome: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E355-E368.
93. Manchikanti L, Pampati V, Cash KA. Protocol for evaluation of the comparative effectiveness of percutaneous ad-hesiolysis and caudal epidural steroid injections in low back and/or lower extremity pain without post surgery syndrome or spinal stenosis. Pain Physician 2010; 13:E91-E110.
94. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of lumbar facet joint nerve blocks in managing chronic low back pain: A randomized, double-blind, controlled trial with a 2-year follow-up. Int J Med Sci 2010; 7:124-135.
95. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V, Fellows B. Comparative effectiveness of a one-year follow-up of thoracic medial branch blocks in management of chronic thoracic pain: A randomized, double-blind active controlled trial. Pain Physician 2010; 13:535-548.
96. Manchikanti L, Singh V, Falco FJE, Cash KA, Fellows B. Comparative outcomes of a 2-year follow-up of cervical medial branch blocks in management of chronic neck pain: A randomized, double-blind controlled trial. Pain Physician 2010; 13:437-450.
97. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. A preliminary report of a randomized double-blind, active controlled trial of fluoroscopic thoracic interlaminar epidural injections in managing chronic thoracic pain. Pain Physician 2010; 13:E357-E369.
98. Manchikanti L, Singh V, Cash KA, Datta S. Management of pain of post lumbar surgery syndrome: One-year results of a randomized, double-blind, active controlled trial of fluoroscopic caudal epi-dural injections. Pain Physician 2010; 13:509-521.
99. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of the effectiveness of lumbar interlaminar epidur-al injections in managing chronic pain of lumbar disc herniation or radiculitis: A randomized, double-blind, controlled trial. Pain Physician 2010; 13:343-355.
100. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. Cervical epidur-al injections in chronic discogenic neck pain without disc herniation or radiculi-tis: Preliminary results of a randomized, double-blind, controlled trial. Pain Physician 2010; 13:E265-E278.